Correlation Between GlaxoSmithKline PLC and Alfa SAB

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Alfa SAB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Alfa SAB into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Alfa SAB de, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Alfa SAB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Alfa SAB. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Alfa SAB.

Diversification Opportunities for GlaxoSmithKline PLC and Alfa SAB

-0.84
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between GlaxoSmithKline and Alfa is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Alfa SAB de in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alfa SAB de and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Alfa SAB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alfa SAB de has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Alfa SAB go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Alfa SAB

Considering the 90-day investment horizon GlaxoSmithKline PLC is expected to generate 54.13 times less return on investment than Alfa SAB. But when comparing it to its historical volatility, GlaxoSmithKline PLC ADR is 1.66 times less risky than Alfa SAB. It trades about 0.0 of its potential returns per unit of risk. Alfa SAB de is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  1,140  in Alfa SAB de on August 24, 2024 and sell it today you would earn a total of  321.00  from holding Alfa SAB de or generate 28.16% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy99.2%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Alfa SAB de

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Alfa SAB de 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Alfa SAB de are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of very weak primary indicators, Alfa SAB displayed solid returns over the last few months and may actually be approaching a breakup point.

GlaxoSmithKline PLC and Alfa SAB Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Alfa SAB

The main advantage of trading using opposite GlaxoSmithKline PLC and Alfa SAB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Alfa SAB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alfa SAB will offset losses from the drop in Alfa SAB's long position.
The idea behind GlaxoSmithKline PLC ADR and Alfa SAB de pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules